These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 19769)

  • 1. Steady-state pharmacokinetics of methadone maintenance patients: renal clearance in low vs high dosages.
    Bellward GD
    Proc West Pharmacol Soc; 1977; 20():483-5. PubMed ID: 19769
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered dose incentive procedures: effects on polydrug use among methadone maintenance patients.
    Stitzer ML; Bickel WK; Bigelow GE
    NIDA Res Monogr; 1987; 76():162-7. PubMed ID: 3125444
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone dosage and retention of patients in maintenance treatment.
    Caplehorn JR; Bell J
    Med J Aust; 1991 Feb; 154(3):195-9. PubMed ID: 1988793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.
    Nilsson MI; Grönbladh L; Widerlöv E; Anggård E
    Eur J Clin Pharmacol; 1983; 25(4):497-501. PubMed ID: 6653644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diazepam on the metabolism of methadone by the liver of methadone-dependent rats.
    Spaulding TC; Minium L; Kotake AN; Takemori AE
    Drug Metab Dispos; 1974; 2(5):458-63. PubMed ID: 4156309
    [No Abstract]   [Full Text] [Related]  

  • 7. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
    Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
    Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C; Smith P; Morrison R; Riek M; Patel A; Schmitt C; Morcos PN; Zhang X
    Addict Biol; 2009 Jul; 14(3):321-7. PubMed ID: 19523046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the risk of AIDS through methadone maintenance treatment.
    Ball JC; Lange WR; Myers CP; Friedman SR
    J Health Soc Behav; 1988 Sep; 29(3):214-26. PubMed ID: 3241064
    [No Abstract]   [Full Text] [Related]  

  • 10. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
    Mitchell TB; Dyer KR; Newcombe D; Somogyi AA; White JM
    Addict Biol; 2006 Jun; 11(2):170-4. PubMed ID: 16800831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of methadone.
    Nilsson MI; Meresaar U; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():66-9. PubMed ID: 6953740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of toxicity of high dose propoxyphene napsylate when used for maintenance treatment of addiction.
    Woody GE; McLellan AT; O'Brien CP; Tennant FS; Mintz J
    Clin Toxicol; 1980 Jun; 16(4):473-8. PubMed ID: 6105935
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
    Pond SM; Kreek MJ; Tong TG; Raghunath J; Benowitz NL
    J Pharmacol Exp Ther; 1985 Apr; 233(1):1-6. PubMed ID: 3981450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone dose and post-mortem blood concentration.
    Caplehorn JR; Drummer OH
    Drug Alcohol Rev; 2002 Dec; 21(4):329-33. PubMed ID: 12537701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fluconazole on the clinical pharmacokinetics of methadone.
    Cobb MN; Desai J; Brown LS; Zannikos PN; Rainey PM
    Clin Pharmacol Ther; 1998 Jun; 63(6):655-62. PubMed ID: 9663180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of methadone in man after a single oral dose.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(6):923-30. PubMed ID: 5081605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.